- Insider Monkey•4 days ago
According to the latest 13F filing of Sio Capital, a global equity market healthcare hedge fund, the investment advisory has further increased its exposure in the healthcare industry. Its recent SEC 13F filing reported an equity portfolio worth $195.76 million, with nearly 90% of the portfolio comprising of healthcare stocks. The hedge fund led by Michael Castor had an […]
- GlobeNewswire•29 days agoChemoCentryx Reports Initial Results from Ongoing Phase Ib Clinical Trial of CCX872 in Patients with Advanced Pancreatic Cancer
MOUNTAIN VIEW, Calif., Sept. 01, 2016-- ChemoCentryx, Inc., today announced initial 12 week overall response rate results from an ongoing open label, single arm Phase Ib clinical trial with CCX872 in patients ...
- GlobeNewswire•last month
MOUNTAIN VIEW, Calif., Aug. 25, 2016-- ChemoCentryx, Inc.,, a clinical-stage biopharmaceutical company developing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, ...
ChemoCentryx, Inc. (CCXI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||6.18 x 100|
|Day's Range||5.51 - 6.20|
|52wk Range||1.92 - 8.30|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.56|
|Avg Vol (3m)||184,139|
|Dividend & Yield||N/A (N/A)|